2015 Report details for project: Childhood Flu Immunisation Programme

Project name: Childhood Flu Immunisation Programme - there are 3 reports for this project: 2015, 2016, 2017
Google search: Google search on project name (opens in new window) opens in new window
Organisation: DOH (D12) - see all reports for this organisation
Report year: 2015 (data is from Sept 2014)
Category: Transformation - see all reports for this category
Description: Influenza is a viral infection of the respiratory system. For some people, especially older people, young infants and people with underlying health conditions, it can cause serious even life-threatening complications and death. The impact of influenza on the population varies widely from year to year due to changes in the virus. However, one recent estimate considered by the Joint Committee on Vaccination and Immunisation (JCVI) suggest that each year, on average, approximately 0.75 million people may consult their GP, approximately 27,000 people may be hospitalised and 4,700 people may die in England because of influenza. Currently the programme provides influenza vaccination on the NHS for people aged 65 years and older and those aged under 65 with certain underlying health conditions (e.g. those with chronic respiratory disease, chronic heart disease, pregnant women etc). JCVI has recommended that the current flu programme is extended to children aged 2 to less than 17 years. DH has a legal obligation, under the 2010 NHS Constitution , to offer new vaccines to the public that are recommended by JCVI and which are shown to be cost effective. The evidence reviewed by JCVI suggests that the extension to the current seasonal flu programme might result in around a 40% reduction in the death and hospitalisation figures shown above across the population, although there is large uncertainty either way in this estimate. For this reason, JCVI recommends that the impact and cost effectiveness of the extended programme be reviewed within five years of the introduction to assess whether the expected benefits have been realised.
DCA (RAG): Amber
DCA text: The MPA RAG rating was Amber at Q2 2014. The review resulted in an Amber rating and a set of recommendations relating to readiness for the 2014/15 flu season. The recommendations highlighted that planning, structures and communications needed to be strengthened. An action plan has been produced which details the progress that has been made against the recommendations. Apart from one recommendation they have all been completed. The outstanding recommendation will be completed before the May 2015 deadline set by the MPA. Planning for the 2015/16 flu season started in October 2014 and communications will be available far earlier than in previous years.
Start date: 2013-09-16
End date: 2018-09-01
Schedule text: The cohorts of children to be immunised in each year of the roll out of this programme are not yet finalised as planning is based on the previous years and dependant on confidence around workforce capacity and vaccine supply.
Baseline: £59.83m
Forecast: £59.83m
Variance: 0.00%
Variance text: Budget variance less than 5%
Whole Life Cost: £436.09m
WLCost text: The whole life cost includes the costs for: vaccine, administration of the vaccine, IT, comms, surveillance and training. The whole life cost is subject to the number of cohorts immunised each year and therefore there may be some variation in the figure as the programme rolls out.
Sourcefile: IPA_2015.csv

Home Selection Search All Reports All Projects (+dates) All Projects (+costs) All Organisations All Years All Categories

Acknowledgement: GMPP data has been re-used under the Open Government Licence.